V-Yes-1 Yamaguchi Sarcoma Viral Related Oncogene Homolog (LYN) (N-Term) Peptid
LYN
Reaktivität: Maus
Wirt: Synthetic
BP, WB
Produktnummer ABIN979669
150,78 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach:
Deutschland
Lieferung in 15 bis 21 Werktagen
Kurzübersicht für V-Yes-1 Yamaguchi Sarcoma Viral Related Oncogene Homolog (LYN) (N-Term) Peptid (ABIN979669)
Target
LYN
(V-Yes-1 Yamaguchi Sarcoma Viral Related Oncogene Homolog (LYN))
Spezies
Maus
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Sequenz
- QGDIVVALYP YDGIHPDDLS FKKGEKMKVL EEHGEWWKAK SLSSKREGFI
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-Lyn Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
V-Yes-1 Yamaguchi Sarcoma Viral Related Oncogene Homolog (LYN) peptide
LYN Reaktivität: Human, Rind (Kuh) Wirt: Synthetic BP, Imm
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- LYN (V-Yes-1 Yamaguchi Sarcoma Viral Related Oncogene Homolog (LYN))
-
Hintergrund
-
The function of this protein remains unknown.
Alias Symbols: AA407514, Hck-2, p53Lyn, p56Lyn
Protein Interaction Partner: Epor,Hcls1,Jak2,Ctla4,Epor,Evl,Jak2
Protein Size: 491 -
Molekulargewicht
- 54 kDa
-
Gen-ID
- 17096
-
NCBI Accession
- NM_010747, NP_034877
-
UniProt
- Q8CEI0
Target
-
Sie sind hier:
